drug

navigated Transcranial Magnetic Stimulation

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by Niuvanniemi Hospital
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DEVICE

Indications

Trials

1
Navigated αTMS in Treatment-resistant Schizophrenia
NCT01941251—Active Not Recruiting

KOLs & investigators

1
Heli Tuppurainen, MD, PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Niuvanniemi Hospital
company
trial
Navigated αTMS in Treatment-resistant Schizophrenia
NA
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
Schizoaffective Disorder
indication
KOL
Heli Tuppurainen, MD, PhD
KOL score —
person